verified SJR 0,771 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom · Adis International Ltd

workspace_premium Q2 — Medicine (miscellaneous) lock Subscription

Clinical Drug Investigation

Clinical Drug Investigation is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology (medical) with an H index of 70. It has a price of 2790 €. It has an SJR impact factor of 0,771 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,771.

Clinical Drug Investigation focuses its scope in these topics and keywords: treatment, costs, perspective, patients, evaluation, patterns, emtansine, infection, herpositive, insomniasafety, ...

ISSN: 1173-2563

Publisher: Adis International Ltd

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,771 Q2

H-index 70

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.790 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,771

H-index

Docs (year)

Docs 3y

311

Total refs

3056

Cites 3y

788

Citable 3y

286

Cites/Doc 2y

2.45

Ref/Doc

37.27

Immediate OA

2790 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical and Demographic Predictors of Improvement during Duloxetine Treatment in Patients with Major Depression

Triple Combination Therapy in Hypertension: The Antihypertensive Efficacy of Treatment with Perindopril, Amlodipine, and Indapamide SR

Cotrimoxazole in the Treatment of Acute Uncomplicated Falciparum Malaria in Nigerian Children

Cost-Effectiveness Analysis of Antiviral Therapies for Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients in China

Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom

Cost Effectiveness of Lopinavir/Ritonavir Compared with Atazanavir in Antiretroviral-Naive Patients

Cost Analysis of Candida Infection among Surgical Intensive Care Unit Patients

Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU

Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Comparison of the Efficacy and Safety of 0.1% Tacrolimus Ointment with Topical Corticosteroids in Adult Patients with Atopic Dermatitis

Comparison of the Effect of Ribosomal Immunotherapy on Plasma Levels of Total IgE and Cytokines IL-4, IL-5, IL-12 and IFN?? in Adult Atopic and Non-Atopic Patients during the Pollen Season

Comparative Study of Teicoplanin vs Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteraemia

SHOW MORE ARTICLES

Combination of Sorafenib and Intensity Modulated Radiotherapy for Unresectable Hepatocellular Carcinoma

A Clinical Study to Examine the Potential Effect of Lansoprazole on the Pharmacokinetics of Bosutinib when Administered Concomitantly to Healthy Subjects

Ciprofloxacin Strongly Inhibits Clozapine Metabolism

Azilsartan Medoxomil

Aripiprazole in the Treatment??of Schizophrenia

Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil in Achieving 24-Hour Blood Pressure Reductions and Ambulatory Blood Pressure Goals

An Open-Label Investigation into Drug-Drug Interactions Between Multiple Doses of Daclatasvir and Single-Dose Cyclosporine or Tacrolimus in Healthy Subjects

Add-On Treatment with Pregabalin for Patients with Uncontrolled Neuropathic Pain Who Have Been Referred to Pain Clinics

A Prospective Survey to Compare the??Suitability Profiles of Over-the-Counter Ibuprofen and Paracetamol Use in a French General Practitioner-Controlled Population

A Phase I Study of Dose-Dense Topotecan Given Upfront to Standard Therapy in Patients with Small Cell Lung Cancer

A Multinational, Observational Study to Investigate the Efficacy, Safety and Tolerability of Acarbose as Add-On or Monotherapy in a Range of Patients: The GlucoVIP Study

FAQs

Clinical Drug Investigation has an SJR of 0,771 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 2790 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Clinical Drug Investigation is 29%.

Clinical Drug Investigation

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Clinical Drug Investigation?

What is the APC / publication cost?

What is the acceptance rate?